4/A

PRIMARY DOCUMENT

Company: GALECTIN THERAPEUTICS INC
Filed: January 31, 2019
Period of Report: January 28, 2019
Accession Number: 0001179022-19-000023

View Document ↗ View on SEC.gov ↗